Dynatronics CORP: directors' dealings · United States · SEC (Form 4)

About Dynatronics CORP

Dynatronics Corp. (NASDAQ: DYNT) is a U.S.-listed company traded on the NASDAQ market in the United States, operating in the medical devices and rehabilitation products space. Founded in 1983 as Dynatronics Laser Corporation, the company has built its business around physical therapy, sports medicine, and rehabilitation technologies. Its headquarters are in Cottonwood Heights, Utah, in the Salt Lake City metropolitan area, giving it a base in a region that supports manufacturing, distribution, and operational execution. Dynatronics’ core activity centers on the design, manufacture, distribution, and commercialization of products used by healthcare professionals, physical therapists, rehabilitation clinics, and sports medicine providers. Its portfolio has traditionally included physical therapy equipment and consumables, rehabilitation solutions, therapeutic modality products, and items aimed at musculoskeletal wellness and recovery. The company’s model combines in-house manufacturing, specialty brands, and multi-channel distribution, with an emphasis on customer service and product availability. From a competitive standpoint, Dynatronics operates in a fragmented but demanding market. It competes with larger healthcare and medical-device players that often benefit from scale, broader sales reach, and heavier R&D budgets. Its competitive edge is more likely to come from specialization, product breadth in niche therapeutic categories, customer relationships, and responsiveness to the needs of clinicians and distributors. For investors, this makes Dynatronics a classic small-cap healthcare name, with greater sensitivity than larger peers to shifts in demand, pricing pressure, inventory management, and access to financing. Geographically, the company is primarily U.S.-based, with operations historically tied to Utah and other domestic facilities used for manufacturing and logistics. Its commercial footprint is mainly concentrated in the United States, although some distribution activity may extend beyond domestic markets depending on product lines and channel strategy. Recent public disclosures have tended to emphasize operational continuity, product portfolio management, and execution discipline rather than large-scale acquisitions or transformational expansion. In the context of SEC Form 4 insider transactions, investors often pay close attention to insider activity, because for a small-cap healthcare company like Dynatronics, ownership signals, liquidity, and capital structure can meaningfully affect market sentiment and valuation.